Intraportal infusion of islet cells

PROCEDURE4 trials

Sponsors

University of Chicago, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Diabetes Mellitus, Type 1Type 1 Diabetes Mellitus

Phase 1

Allogenic Islet Cell Transplantation

Active, not recruitingNCT00160732

University of ChicagoDiabetes Mellitus, Type 1

Start: 2003-10-31End: 2030-10-31Target: 50Updated: 2025-12-08

Phase 2

LEA29Y (Belatacept) Emory Edmonton Protocol

CompletedNCT00468403

National Institute of Allergy and Infectious Diseases (NIAID)Type 1 Diabetes Mellitus

Start: 2008-10-31End: 2013-04-30Updated: 2016-04-07

Islet Transplantation in Type 1 Diabetic Kidney Allograft

RecruitingNCT01241864

University of ChicagoDiabetes Mellitus, Type 1

Start: 2010-12-31End: 2026-12-31Target: 10Updated: 2025-12-08

Unknown Phase

Islet Transplantation in Patients With Brittle Type I Diabetes

RecruitingNCT01630850

University of ChicagoDiabetes Mellitus, Type 1

Start: 2012-05-31End: 2030-06-30Target: 20Updated: 2025-12-09